# Suprefort

> A natural pancreas peptide complex (Cytomax A-7) — the extract-based counterpart to Pancragen, targeting pancreatic tissue.

- Also known as: A-7 pancreas peptide, pancreatic peptide complex
- Class: Bioregulators, Metabolic
- FDA approved: No
- Canonical page: https://americanpeptide.com/catalog/suprefort

## Overview

Suprefort is a natural peptide complex extracted from pancreatic tissue (peptide complex A-7), part of the Russian Cytomax / Revilab bioregulator line. It is the extract-based pancreatic counterpart to the synthetic peptide Pancragen, marketed within the Khavinson tradition for carbohydrate-metabolism and pancreatic support.

Suprefort is the pancreas-directed natural bioregulator of the Cytomax / Revilab line. It pairs with Pancragen, the synthetic pancreatic short peptide already catalogued: Suprefort is the natural pancreatic extract, Pancragen the defined synthetic peptide modeled on the same tissue.

As a tissue extract it is a standardized polypeptide fraction with no single molecular formula or sequence. Its metabolic claims — supporting carbohydrate metabolism and pancreatic function — come from the same concentrated research tradition as the rest of the series, with limited independent replication, and it is not FDA-approved.

## Mechanism

Proposed tissue-selective (bioregulator) modulation of pancreatic gene expression, in the same lineage as the synthetic pancreas peptide Pancragen.

## Research areas

Studied in: Carbohydrate metabolism, Aging biology, Peptide bioregulators.

Guides on this site:

- [Longevity & Aging](https://americanpeptide.com/research-areas/longevity-aging): Peptides studied across the aging axis — senescence, NAD+, and resilience.
- [Peptide Bioregulators](https://americanpeptide.com/research-areas/bioregulators): Short, tissue-specific peptides proposed to regulate gene expression — the Khavinson series.

## Key research

- Pancreatic bioregulator — a natural pancreas peptide extract (complex A-7), the extract counterpart to synthetic Pancragen.
- Metabolic focus — marketed for carbohydrate metabolism and pancreatic support within Khavinson protocols.
- A tissue extract — a polypeptide fraction with no single formula or sequence.
- Evidence quality — concentrated in one research tradition; preliminary. Not FDA-approved.

## Storage, handling & synthesis

**Synthesis.** Suprefort is a natural pancreas peptide extract (complex A-7), a fractionated polypeptide preparation rather than a synthesized peptide. Batch-to-batch consistency and characterization, not coupling chemistry, are the quality challenge.

## FAQs

### What is Suprefort?

Suprefort is a natural pancreas peptide complex (Cytomax A-7), marketed for metabolic and pancreatic support — the extract-based counterpart to the synthetic peptide Pancragen.

### How does it relate to Pancragen?

Suprefort is the natural pancreatic extract; Pancragen is the defined synthetic peptide modeled on the same tissue.

### Does it have a molecular formula?

No — it is a tissue extract (a polypeptide fraction), so it has no single sequence or molecular formula.

### Is Suprefort approved?

No — it is a research compound / supplement, not FDA-approved. This page is a research and educational reference.

---

Source: AmericanPeptide.com — https://americanpeptide.com/catalog/suprefort
Data license: CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). Attribution: AmericanPeptide.com.
Research reference only — computational and educational content, not medical advice.